Fundraising Fox
/People
Sign in

Chris Buyse

Investor

Board Member at Fund+ · Director at iTeos Therapeutics

Antwerp Metropolitan Area

Find your path to Chris

266 people in our graph can introduce you to Chris.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Willem Broekaert to introduce you to Chris

You →Willem · together at CropDesign - a BASF Plant Science Company (2006) →Chris

Ask Jamie Chen to introduce you to Chris

You →Jamie · 2 people · together at BONE THERAPEUTICS S.A. →Chris

Ask Sam Okafor to introduce you to Chris

You →Sam · 2 people · together at Eyedpharma →Chris

Sign up to find every way you can get introduced to Chris

  • Your email: the people you already email who know Chris
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Chris
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Former CFO of ThromboGenics and CropDesign with 30 years in international company finance; currently serves as independent board member of life sciences companies such as Hyloris and Inventiva Pharma.

Director at iTeos Therapeutics

Intro paths

→

In turn, Chris can intro founders to iTeos Therapeutics's investors below.

iTeos Therapeutics's investors · 10

6 Dimensions CapitalGrand Cayman · since 2020Curative VenturesDallas · since 2020Fund+Leuven · $5.5M – $16.5M checks · since 2020HBM PartnersZug · $5M – $50M checks · since 2020InvusNew York · since 2020Janus Henderson InvestorsLondon · since 2020MPM BioImpactBoston · $1M – $15M checks · since 2020RA CapitalBoston · since 2020RTW Investments L.P.New York · since 2020VIVES PartnersWavre · $108K – $7.6M checks · since 2020

Co-founders at iTeos Therapeutics

MDMichel Detheux
Michel DetheuxExecutive Officer, Director

Experience

  1. Foundation for Education to Improve Family PlanningManaging Directorcurrent2024 — presentLondon Area, United Kingdom
  2. Louis-Jeantet FoundationMember Board of Trusteescurrent2020 — presentGeneva, Switzerland
  3. Francqui FoundationBoard Membercurrent2018 — presentBrussels Metropolitan Area
  4. FundPlusMember Board of Directorscurrent2015 — presentLeuven, Flemish Region, Belgium
  5. FundPlusManaging Partner2014 — 2023Leuven
  6. IPA (ImmunoPrecise Antibodies)Board Member2023 — 2025Victoria, British Columbia, Canada
  7. Inventiva PharmaIndependant board member and Chairman of the Audit Committee2017 — 2024Paris/Dijon
  8. Hyloris PharmaceuticalsBoard Member & Member Audit Committee2020 — 2024Liège
  9. EyeD PharmaMember Board Of Directors2019 — 2023Liège, Wallonië, België
  10. CelyadIndependant Boardmember2008 — 2022Brussels Metropolitan Area
  11. BioxodesBoard Member2011 — 2020Brussels
  12. iTeos Therapeutics SAMember Board Of Directors2009 — 2020Gosselies/Boston
  13. Keyware Technologies NVCFO and CEO ad Interim, currently Board Member2002 — 2019
  14. BONE THERAPEUTICS S.A.Independant Boardmember2010 — 2018Charleroi Area, Belgium
  15. ThromboGenics NVCFO & Board Member2006 — 2014Leuven
  16. CropDesign - a BASF Plant Science CompanyCFO2006Ghent Metropolitan Area
  17. VerizonFinance Director Belux2003 — 2006Brussels Metropolitan Area
  18. Spector Photo GroupGroup Controller1998 — 2001Ghent Metropolitan Area
  19. SITA NEWS (Northern Europe Waste Services)Financial Controller1992 — 1998Brussels Area, Belgium, Paris and Dusseldorf
  20. UnileverInternal Auditor and Management Accountant1988 — 1992Brussels Area, Belgium and Antwerp

Skills & more

Mergers7Change Management8Corporate Finance8Business Strategy21Biotechnology4Financial Reporting2Due Diligence9Venture Capital3Mergers & Acquisitions14Internal Audit8Start-ups5Finance22
+2 moreFinancial AnalysisRestructuring

From Chris's professional profile.

Colleagues at Fund+

Bart De Leeuw
Partner/CFO at Fund+
Caroline Goddeeris
Partner at Fund+
Désiré Collen
Honorary Chairman / Board Observer at Fund+
Diane De Wyngaert
Administrative Assistant at Fund+
François Fontaine
Board Member at Fund+
Halina Novak
Principal at Fund+
Kenneth Bonheure
Board Member at Fund+
Luc Debruyne
Chairman of the Board at Fund+

Frequently asked questions

Who is Chris Buyse?
Former CFO of ThromboGenics and CropDesign with 30 years in international company finance; currently serves as independent board member of life sciences companies such as Hyloris and Inventiva Pharma.
Where does Chris Buyse work?
Chris Buyse is Board Member at Fund+.
Where did Chris Buyse go to school?
Chris Buyse studied at Vlerick Business School (PUB, Business Administration and Management); University of Antwerp (TEW, Toegepaste economie (Applied economics)); Georgetown University (Summer Course International management).

Same school

Shared employers